5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 765.40▼ | 795.80▼ |
MA10 | N/A | N/A | N/A | 757.30▼ | 853.20▼ |
MA20 | N/A | N/A | N/A | 801.15▼ | 949.30▼ |
MA50 | N/A | N/A | N/A | 882.86▼ | 1,047.40▼ |
MA100 | N/A | N/A | N/A | 958.91▼ | 955.80▼ |
MA200 | N/A | N/A | N/A | 1,044.84▼ | 703.77▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 2.323▲ | -26.526▼ |
RSI | N/A | N/A | N/A | 35.401▼ | 34.747▼ |
STOCH | N/A | N/A | N/A | 42.758 | 12.544▼ |
WILL %R | N/A | N/A | N/A | -87.743▼ | -95.955▼ |
CCI | N/A | N/A | N/A | -63.233 | -89.312 |
Thursday, June 30, 2022 08:29 AM
As a quick introduction, Treatt is a chemical company that specialises in creating and selling natural extracts and ingredients for foodstuff, beverage, fragrance, and consumer goods markets. It ...
|
Thursday, June 30, 2022 01:41 AM
Ultimovacs’ second technology approach, based on the proprietary Tetanus-Epitope-Targeting (TET) platform, combines tumor-specific peptides and adjuvant in the same molecule, and entered Phase I ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/22 | 750.00 | 769.76 | 741.53 | 743.00 | 110,176 |
30/06/22 | 754.00 | 759.00 | 739.00 | 759.00 | 97,450 |
29/06/22 | 769.00 | 777.50 | 748.00 | 776.00 | 74,008 |
28/06/22 | 776.00 | 791.75 | 767.00 | 773.00 | 49,834 |
27/06/22 | 760.00 | 800.00 | 757.15 | 776.00 | 179,616 |
24/06/22 | 750.00 | 765.00 | 729.40 | 760.00 | 184,224 |
22/06/22 | 750.00 | 757.80 | 739.00 | 751.00 | 45,662 |
21/06/22 | 744.00 | 782.95 | 743.00 | 766.00 | 107,787 |
20/06/22 | 725.00 | 752.00 | 725.00 | 743.00 | 177,755 |
17/06/22 | 768.00 | 794.3028 | 726.00 | 726.00 | 138,639 |
|
|
||||
|
|
||||
|
|